drugset / Trial / NCT04780841
A Study Evaluating the Safety and Efficacy of RDX013 for the Treatment of Hyperkalemia
RandomizedSequentialSingle-blindTreatment
Summary
The purpose of this study is to evaluate the ability of RDX013 to lower serum potassium in patients with chronic kidney disease with elevated serum potassium levels
Timeline
- Start
- 2021-01-11
- Primary completion
- 2021-12-28
- Completion
- 2022-03-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RDX013 | Unknown | — | Oral |
Indications
No indication recorded.